pre-update Archives

Press Release

Certara Reports Fourth Quarter 2023 Financial Results

Provides Full Year 2024 Financial Guidance PRINCETON, N.J.— February 29, 2024-- Certara, Inc. (Nasdaq: CERT), a…

CertaraFebruary 29, 2024

Publication

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…

CertaraFebruary 23, 2024

Fact Sheet

Biostatistics Consulting, Statistical & PKPD Programming and Data Management Oversight

CertaraFebruary 23, 2024

Press Coverage

Planning for a Successful EMA Policy 0070 Submission

CertaraFebruary 22, 2024

On-Demand Webinar

RAPS: How Will Generative AI Take Your Regulatory and Medical Writing Program to the Next Level?

Drug developers face increasing pressures to accelerate the drug development process, including reducing submission timelines.…

CertaraFebruary 22, 2024

Blog

How to Navigate the FDA Landscape for an Orphan Drug

Rare diseases are a public health priority. FDA has launched several programs and a final…

CertaraFebruary 21, 2024

Blog

Dose Optimization Considerations for Targeted Radiation Therapies

The acquisitions of targeted radiation therapy companies (TRT) Point Biopharma by Eli Lilly and RayzeBio…

CertaraFebruary 16, 2024

Publication

The interaction of core modules as a basis for elucidating network behavior determining Parkinson’s disease pathogenesis

It is well-established that misfolded alpha-synuclein (alpha-syn) is a histopathological marker of Parkinson's disease. Given…

CertaraFebruary 14, 2024

On-Demand Webinar

Advancing Services & Software for INDs: How to Expedite IND Filing with a Subscription Model

When choosing how to accomplish your IND submission, there can be many elements to the…

CertaraFebruary 13, 2024

Conference

The 15th Japan Safety Pharmacology Society

CertaraFebruary 13, 2024

pre-update